Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutger W H M Staffhorst

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|February 22, 2005
Cisplatin nanocapsulesAnton I P M de Kroon, Rutger W H M Staffhorst, Ben de Kruijff, et al.
Molecular Cancer Therapeutics|August 25, 2006
Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatinIrene H L Hamelers, Esther van Loenen, Rutger W H M Staffhorst, et al.
Nature Medicine|January 12, 2002
Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicityKoert N J Burger, Rutger W H M Staffhorst, Hanke C de Vijlder, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificityMaria J Velinova, Rutger W H M Staffhorst, Willem J M Mulder, et al.
Anti-Cancer Drugs|July 3, 2008
Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenograftsRutger W H M Staffhorst, Kasper van der Born, Caroline A M Erkelens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosisIrene H L Hamelers, Rutger W H M Staffhorst, Jarno Voortman, et al.
Biochemistry|January 25, 2008
Is there a preferential interaction between cholesterol and tryptophan residues in membrane proteins?Andrea Holt, Rodrigo F M de Almeida, Thomas K M Nyholm, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|February 22, 2005
Cisplatin nanocapsulesAnton I P M de Kroon, Rutger W H M Staffhorst, Ben de Kruijff, et al.
Molecular Cancer Therapeutics|August 25, 2006
Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatinIrene H L Hamelers, Esther van Loenen, Rutger W H M Staffhorst, et al.
Nature Medicine|January 12, 2002
Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicityKoert N J Burger, Rutger W H M Staffhorst, Hanke C de Vijlder, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificityMaria J Velinova, Rutger W H M Staffhorst, Willem J M Mulder, et al.
Anti-Cancer Drugs|July 3, 2008
Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenograftsRutger W H M Staffhorst, Kasper van der Born, Caroline A M Erkelens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosisIrene H L Hamelers, Rutger W H M Staffhorst, Jarno Voortman, et al.
Biochemistry|January 25, 2008
Is there a preferential interaction between cholesterol and tryptophan residues in membrane proteins?Andrea Holt, Rodrigo F M de Almeida, Thomas K M Nyholm, et al.
Pageof 1